[Federal Register Volume 72, Number 121 (Monday, June 25, 2007)]
[Notices]
[Page 34689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-12173]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) and the Assistant Secretary for Health have taken final action in 
the following case:
    Joy Bryant, University of Oklahoma Health Sciences Center: Based on 
the report of an investigation conducted by the University of Oklahoma 
Health Sciences Center (OUHSC) and additional analysis conducted by the 
Office of Research Integrity during its oversight review, the U.S. 
Public Health Service (PHS) found that Ms. Joy Bryant, Tribal Efforts 
Against Lead (TEAL) phlebotomist, OUHSC, engaged in scientific 
misconduct in research supported by National Institute of Environmental 
Health Sciences (NIEHS), National Institutes of Health (NIH), grant R01 
ES008755.
    Specifically, Ms. Bryant falsified research in the TEAL study by 
substituting or conspiring with another phlebotomist to substitute her 
blood or blood of another phlebotomist for blood samples of 10-15 child 
participants in the TEAL study.
    Ms. Bryant has entered into a Voluntary Exclusion Agreement 
(Agreement) in which she has voluntarily agreed, for a period of three 
(3) years, beginning on May 30, 2007:
    (1) To exclude herself from any contracting or subcontracting with 
any agency of the United States Government and from eligibility or 
involvement in nonprocurement programs of the United States Government 
as defined in HHS' implementation of OMB Guidelines to Agencies on 
Governmentwide Debarment and Suspension at 2 CFR part 376, et seq.; and
    (2) to exclude herself from serving in any advisory capacity to 
PHS, including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant.

FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8800.

John E. Dahlberg,
Acting Director, Office of Research Integrity.
[FR Doc. E7-12173 Filed 6-22-07; 8:45 am]
BILLING CODE 4150-31-P